𝔖 Bobbio Scriptorium

✦ LIBER ✦

Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin

✍ Scribed by Bybee, Kevin A.; Lee, John H.; O'Keefe, James H.

Book ID: 120646112
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 597 KB
Volume: 24
Category: Article
ISSN: 0300-7995
DOI: 10.1185/030079908X292001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMPACT OF ASPIRIN DOSE ON LONG TERM CLIN

IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL

✍ Kovacic, Jason Ciril; Mehran, Roxana; Dangas, George; Claessen, Bimmer; Parise, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 168 KB

TCT-236 Clinical Profile And Impact Of A

TCT-236 Clinical Profile And Impact Of A Family History Of Premature Coronary Artery Disease On Long-term Clinical Ischemic Events In Patients Undergoing PCI For STEMI: Analysis From The HORIZONS-AMI Trial. Revascularization And Stents In Acute Myocardial Infarction) Trial.

✍ Ertelt, Konstanze; Genereux, Philippe; Mintz, Gary S.; Kirtane, Ajay J.; McAndre 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Gamma vascular brachytherapy neutralizes

Gamma vascular brachytherapy neutralizes the negative impact of diabetes mellitus on clinical outcomes after PCI for in-stent restenosis: pooled data from Gamma I, Gamma II, and SCRIPPS III trials

✍ Milena G. Adamian; Issam Moussa; Roxana Mehran; George Dangas; Alexandra J. Lans 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Evaluation of the effect of oral verapam

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

✍ H.P. Bestehorn; F.J. Neumann; H.J. Büttneret 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Evaluation of the effect of oral verapam

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

✍ Hans-Peter Bestehorn; Franz-Josef Neumann; Heinz Joachim Büttner; Peter Betz; Pe 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 131 KB